MSK Abstracts Make Up 12% of all ASCO Meeting Abstracts Published

Posted on by

The abstracts selected for publication from this year’s ASCO Annual Meeting include 258 (12%) abstracts from Memorial Sloan Kettering out of a total of 2,100 abstracts. The top 7 MSK authors all published 10 or more abstracts: J. D. Wolchok (18), N. A. Rizvi (14), C. A. Hudis (13), M. G. Kris (12),  R. J. Motzer (12), C. S. Sima (11), and J. Baselga (10) . The top three categories of articles (as determined by ASCO) were Gastrointestinal (Noncolorectal) Cancer (22), Lung Cancer-Non-Small Cell Metastatic (21), and Genitourinary (Prostate) Cancer (20). The abstracts included two on the historic IBM Watson Oncology application being implemented at MSK.

Please click to download the list of all MSK Abstracts as a PDF or an EndNote library. Contact us if you have any questions, at 212-639-7439 or asklibrarian@mskcc.org.

 

NIH Innovation Corps (I-Corps™) Team Training Pilot Program

Posted on by

The National Institutes of Health (NIH) and National Science Foundation (NSF) have teamed up to develop a new program that will provide NIH-funded scientists with hands-on entrepreneurship training.

Over the course of 9 weeks, participants will engage in a hypothesis-driven approach to customer discovery, learning from experts in the biotechnology and life science industries. The curriculum is modeled after the NSF Innovation Corps program, with the goal of accelerating the development of new and emerging technologies for the detection, diagnosis, treatment, and prevention of disease.

Applications for the pilot program will be accepted through August 7, 2014. For requirements and curriculum details, see I-Corps™ at NIH and Funding Opportunity Announcement (FOA) number PAR-14-261.

“Cancer Will be Defeated!” – the Words of MSK’s Dr. Joan Massague and more…

Posted on by
  • One of MSK’s most distinguished scientists, Dr. Joan Massagué, Chair of the Cancer Biology and Genetics Program and Director of the Sloan Kettering Institute, declared that “cancer will be defeated! “ Dr. Massagué made the statement at the Universidad Internacional Menendez Pelayo in Spain. He predicted that cancer will be overcome in 50 years. The sequencing of the human genome is the seminal achievement that will make this a reality.
  • Three-dimensional mammograms are more precise and detect more cancers than standard imaging and some healthcare providers are staunch supporters of this technology. Others, however, are not convinced due to the extra cost and added radiation exposure. MSK’s Dr. Carol Lee, an Attending Radiologist, does not think it should be the standard of care at this point because there is still a lot to learn about this form of imaging.
  • MSK’s Dr. Allison Kipitz-Snyderman led a study of data from patients with invasive or noninvasive breast cancer, invasive colorectal cancer, head and neck, lung or pancreatic cancers, or non–Hodgkin’s lymphoma, to determine the effects of long-term use of central venous catheters (CVC) on risk of infection.  They concluded that prolonged use of CVC’s in cancer patients can bring about increased risk of infection in the over 65 age group.